Neda Rasouli

17PUBLICATIONS
52CO-AUTHORS
HaematologyPharmacogenomicsMolecular targetsExercise physiologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 21, 2026
Oral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes?

|Mar 04, 2026
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial.

Joakim Nordanstig, Ecenur Guder Arslan, Andrei-Mircea Catarig

|Dec 23, 2025
Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Steven E Kahn, Mark Tripputi, John M Lachin

|Jun 21, 2025
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial.

Neda Rasouli, Ecenur Guder Arslan, Andrei-Mircea Catarig

|Feb 25, 2025
Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Kristina M Utzschneider, Mark Tripputi, Nicole M Butera

|Feb 20, 2025
Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohort.

Sun H Kim, Vanita R Aroda, Ranee Chatterjee

Pageof 3

Frequent Collaborators

6 joint publications

Kristina Utzschneider

5 joint publications

Ralph A DeFronzo

4 joint publications

Ashok Balasubramanyam

4 joint publications

William I Sivitz